Fibroblast-Activated Protein Inhibitor PET/CT: Cancer Diagnosis and Management
Fibroblast activation protein (FAP), overexpressed on cancer-associated fibroblasts (CAFs), is a novel target for molecular imaging of various tumors. Recently, the development of several small-molecule FAP inhibitors for radiolabeling with 68Ga has resulted in the emergence of studies evaluating it...
Guardado en:
Autores principales: | Serkan Kuyumcu, Yasemin Sanli, Rathan M. Subramaniam |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f6b7392e8fb940db825892af269b3b9a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical Significance of Diffusely Increased Uptake of 68Ga-FAPI in Thyroid Gland
por: Huipan Liu, et al.
Publicado: (2021) -
Understanding the Role of Fibroblasts following a 3D Tumoroid Implantation for Breast Tumor Formation
por: Girdhari Rijal
Publicado: (2021) -
68Ga-PSMA11 PET/CT for biochemically recurrent prostate cancer: Influence of dual-time and PMT- vs SiPM-based detectors
por: Heying Duan, et al.
Publicado: (2022) -
Radioligands Targeting Fibroblast Activation Protein (FAP)
por: Thomas Lindner, et al.
Publicado: (2021) -
An Emerging Role for Calcium Signaling in Cancer-Associated Fibroblasts
por: Francisco Sadras, et al.
Publicado: (2021)